AdobeStock_210711813

Self Care Forum venous disease fact sheet

2021-06-11T09:16:00+01:00By

A summary of recommendations for advising patients and the public on managing venous disease

AdobeStock_133646819

HEART UK Managing hyperlipidaemia and COVID-19

2021-02-17T14:44:00+00:00By HEART UK

A summary of collated current evidence surrounding the safety of lipid-lowering medications in patients who have COVID-19

doctor with elderly man

Consensus guideline on the holistic management of patients requiring anticoagulation

2020-06-03T06:57:00+01:00By Working party–Fay Antoniou Martins Merriman Patrickson Uprichard

This guideline was developed by a multidisciplinary expert panel: Fay M et al with the support of an educational grant from Bayer plc.

Pad+stethoscope 640x426

Stable peripheral arterial disease guideline

2018-12-07T15:50:00+00:00By Working party—Begg Antoniou Fay Garnham Nuttall

This guideline was developed by a multidisciplinary expert panel: Begg A et al with the support of a grant from Bayer plc.

Pregnant women with GP AS

Stable coronary artery disease guideline

2018-12-04T12:08:00+00:00By Working party­—Fay Banerjee Begg Bostock-Cox Gordon

This guideline was developed by a multidisciplinary expert panel: Fay M et al with the support of a grant from Bayer plc.

erythrocytes

SIGN antithrombotics guideline

2014-11-06T00:00:00+00:00By

A clear SIGN guideline summary exploring antiplatelet and anticoagulant agents and indications for their use, including cardiac and cerebrovascular disease.

Resource hub

  • Practical guide to recording ankle brachial pressure index (ABPI)

Educational resources

On-demand index image2

The impact of DOACs on stroke in patients with NVAF: practical considerations for those with comorbidities

Commissioned by Bristol Myers Squibb on behalf of the BMS – Pfizer Alliance

These promotional videos have been funded by Bristol Myers Squibb on behalf of the BMS / Pfizer Alliance and developed in conjunction with Guidelines.   The promotional content on this page is intended for UK healthcare professionals only.
View ELIQUIS (apixaban) prescribing and adverse event reporting information
432-GB-2100966 | Date of preparation: January 2022

Animation index image

Changes to the NICE atrial fibrillation (AF) guideline and anticoagulation treatment options—what do they mean to you?

Commissioned by Bayer plc

This promotional animation has been commissioned by Bayer plc and developed in partnership with Guidelines
View Xarelto (rivaroxaban) prescribing information and adverse event reporting
PP-XAR-GB-2154 December 2021

Daiichi Sankyo logo

Bempedoic acid (Nilemdo®▼) and Bempedoic acid / ezetimibe (Nustendi®▼) SMC card

Commissioned and funded by Daiichi Sankyo

The production of this Guidelines card has been commissioned and funded by Daiichi Sankyo UK. This content is for healthcare professionals only.
View Bempedoic acid (Nilemdo®) & Bempedoic acid and ezetimibe (Nustendi®) prescribing and adverse event reporting information
BEM/21/0777 December 2021

Jardiance SMC guidance card index image

Empagliflozin (Jardiance®) 10mg film-coated tablets SMC2396

Promotional material from the Boehringer Ingelheim and Lilly Alliance

The production of this Guidelines  summary card has been commissioned by the Boehringer Ingelheim and Lilly Alliance.
View Jardiance® (empagliflozin) prescribing and adverse event reporting information for Great Britain and Northern Ireland.
PC-GB-105816 October 2021

website index image

Updates in best practice management of venous thromboembolism

Commissioned by Bristol Myers Squibb on behalf of the BMS – Pfizer Alliance

These promotional videos have been funded by Bristol Myers Squibb on behalf of the BMS / Pfizer Alliance and developed in conjunction with Guidelines.  The promotional content on this page is intended for UK healthcare professionals only.
View ELIQUIS (apixaban) prescribing and adverse event reporting information
432-GB-2100782 | Date of preparation: September 2021